Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David Hodgson
AddedMar 31, 2024
UpdatedJun 28, 2026
David Hodgson

David Hodgson

Board Member, General Atlantic

CrunchbaseLinkedIn

David Hodgson's Career

General Atlantic
General Atlantic

New York City, NY, US

Board Member· Board
Royalty Pharma
Royalty Pharma

New York City, NY, US

Board Member· Board
TriNet
TriNet

Dublin, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David Hodgson's Career

General Atlantic
General Atlantic
Investment FirmInvestment Firm4961980New York City, NY, US
Board Member· Board

Recent news

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega roundTechCrunch · 2026
Almost 90 new unicorns have been minted so far this year — here they areTechCrunch · 2026
Novak Djokovic has a new job — advisor to private equity firm General AtlanticTechCrunch · 2026

Leadership at General Atlantic

Loek van den BoogLoek van den BoogBoard Member
Mark GainsboroughMark GainsboroughBoard Member
Pedro ParentePedro ParenteBoard Member
Nigel MorrisNigel MorrisBoard Member
Vittorio ColaoVittorio ColaoBoard Member
William E. FordWilliam E. FordBoard Member

Similar to General Atlantic

General CatalystGeneral CatalystCambridge, MA, USest. 2000General CatalystCambridge, MA, US · est. 2000

General Catalyst: A U.S.-based VC firm investing in early-stage and growth global companies.

Investment Firm200
General Global CapitalGeneral Global CapitalSan Francisco, CA, USest. 2019General Global CapitalSan Francisco, CA, US · est. 2019

GenGlobal: A tech-focused investment firm specializing in growth-stage investments across diverse sectors.

Investment Firm30
Atlas VentureAtlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29
Summit PartnersSummit PartnersBoston, MA, USest. 1984Summit PartnersBoston, MA, US · est. 1984

Summit Partners: A US-based private equity firm specializing in tech, healthcare, and growth industries.

Investment Firm191
Royalty Pharma
Royalty Pharma
Public751996New York City, NY, US
Board Member· Board

Leadership at Royalty Pharma

Rory RiggsRory RiggsBoard Member
Cathy EngelbertCathy EngelbertBoard Member
Pablo G LegorretaPablo G LegorretaBoard Member
Henry FernandezHenry FernandezBoard Member
Ted LoveTed LoveBoard Member
Christopher HiteChristopher HiteBoard Member

Similar to Royalty Pharma

Roivant SciencesRoivant SciencesNew York City, NY, USDrug Developmentest. 2014Roivant SciencesNew York City, NY, US · est. 2014

NY-based Roivant Sciences is a biopharmaceutical firm dedicated to advancing promising drugs for patient care.

Public · $2.5B267
XOMA RoyaltyXOMA RoyaltyEmeryville, CA, USRoyalty Acquisitionest. 1981XOMA RoyaltyEmeryville, CA, US · est. 1981

XOMA Corporation, a biotech royalty aggregator, acquires economic rights to clinical candidates, aiding health improvement.

Public · $295.8M96
AstraZenecaAstraZenecaCambridge, Cambridgeshire, GBPharmaceuticalsest. 1999AstraZenecaCambridge, Cambridgeshire, GB · est. 1999

AstraZeneca PLC: A British-Swedish firm specializing in research, manufacturing, and sales of pharmaceuticals.

Public · $3.8B83.5k
PharmosPharmosIselin, NJ, USDrug Developmentest. 1982PharmosIselin, NJ, US · est. 1982

W World Corp.: A bio-pharmaceutical firm innovating new drugs for neuroinflammatory disorders.

Public · $9.5M2
TriNet
TriNet
Public$856.7M3.6k1988Dublin, CA, US
Board Member· Board

Recent news

TriNet Announces Fourth Quarter, Fiscal Year 2025 Results, and Full Year 2026 GuidanceTriNet · 2026
TriNet Appoints Mala Murthy as Chief Financial Officer, Succeeding Kelly TuminelliTriNet · 2025
TriNet Ranked #1 in Newsweek’s Excellence 1000 Index 2024TriNet · 2024

Leadership at TriNet

Mala MurthyMala MurthyExecutive Vice President and Chief Financial Officer
Mike SimondsMike SimondsPresident & CEO
Paul ChamberlainPaul ChamberlainBoard Member
Martin BabinecMartin BabinecFounder
Jacqueline KosecoffJacqueline KosecoffBoard Member
Ralph ClarkRalph ClarkBoard Member

Similar to TriNet

InsperityInsperityKingwood, TX, USHR Servicesest. 1986InsperityKingwood, TX, US · est. 1986

Insperity, Inc.: A leading US-based professional employer organization providing HR services to SMEs.

Public4.1k
RipplingRipplingSan Francisco, CA, USHR Tech, Payrollest. 2016RipplingSan Francisco, CA, US · est. 2016

Rippling: Unified platform for HR, IT, & Finance services globally.

Series G · $1.6B2.5k
Employee NavigatorEmployee NavigatorBethesda, MD, USBenefits Administration, HR Softwareest. 2008Employee NavigatorBethesda, MD, US · est. 2008

Employee Navigator offers an integrated benefits administration and HR platform for insurance brokers and employers.

Series C · $134M300
Fullstack PEOFullstack PEOIndianapolis, IN, USHR Servicesest. 2018Fullstack PEOIndianapolis, IN, US · est. 2018

FullStack PEO: Comprehensive provider of payroll, HR, benefits, and compliance services.

Seed · $960k175

David Hodgson's Co-Investors

Rohan SethRohan SethCo-invested · Synapticure SeedJoe KrausJoe KrausCo-invested · Synapticure SeedRonald ConwayRonald ConwayCo-invested · Synapticure SeedJeff HuberJeff HuberCo-invested · Synapticure SeedGary BisbeeGary BisbeeCo-invested · Synapticure SeedAdam KoppelAdam KoppelCo-invested · Synapticure SeedDivya SilbermannDivya SilbermannCo-invested · Synapticure Seed

David Hodgson's Similar Executives & Operators

Jay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to David Hodgson

Adam CowherdAdam CowherdCo-Founder · AmplifyXJohn RyuJohn RyuCo-Founder · HypothesisEric T. SchmidtEric T. SchmidtBoard Member · Relmada TherapeuticsChris HarmsChris HarmsCo-Founder · Branders.comChris CapdevilaChris CapdevilaFounder · Founders PadDave SaxenaDave SaxenaFounder · Emles Advisors